Profile data is unavailable for this security.
About the company
Saroja Pharma Industries India Limited is an India-based pharmaceutical and healthcare company. The Company is in Active Pharmaceuticals Ingredients (APIS), Specialty Chemicals, Intermediates for Pharma trading. It operates as a trader, exporter and supplier of Specialty Chemicals. It supplies products like Liquide Bromine used as an Agro Intermediate, Ethyl Acetate used as an API solvent as an agro intermediate, and other drugs that are used for human and veterinary medicines, and some of them are API solvents. It offers products in three categories, which include Chemical, Pharma Intermediary, and Veterinary Pharma API. Its Chemical products include Liquid Bromine, Ethyl Acetate, Thionyl Chloride, Para Nitro Phenol, Toluene N. G, and Benzyl Chloride. The Company’s Veterinary Pharma API products include Bromhexine HCL BP Grade, Triclabendazole, Fenbendazole BP Vet, Nitroxynil BP Vet, Oxfendazole BP Vet, Albendazole USP, Rafoxanide BP Vet, and Febantel EP, among others.
- Revenue in INR (TTM)733.63m
- Net income in INR12.69m
- Incorporated2019
- Employees12.00
- LocationSaroja Pharma Industries India Ltd209, 2Nd Floor,Ecstasy Buisness Park, City Of Joy CompMUMBAI 400080IndiaIND
- Phone+91 2 220810011
- Websitehttps://www.sarojapharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parenteral Drugs (India) Ltd | 84.96m | -763.62m | 91.12m | -- | -- | -- | -- | 1.07 | -25.61 | -25.61 | 2.85 | -276.37 | 0.0162 | 4.17 | 0.9266 | -- | -14.52 | -17.82 | -- | -- | 35.67 | 40.22 | -898.77 | -191.93 | 0.055 | -0.5192 | -- | -- | -30.17 | -48.70 | 37.26 | -- | -- | -- |
| Ortin Global Ltd | 1.33m | -9.49m | 97.82m | 3.00 | -- | 7.53 | -- | 73.77 | -1.17 | -1.17 | 0.1634 | 1.60 | 0.0338 | 8.84 | 0.1503 | 442,000.00 | -24.15 | -6.49 | -40.57 | -13.44 | 34.01 | 35.99 | -715.61 | -33.91 | 2.08 | -- | 0.4171 | -- | -83.79 | -71.96 | 89.47 | -- | -- | -- |
| Saroja Pharma Industries India Ltd | 733.63m | 12.69m | 144.94m | 12.00 | 11.38 | 0.8922 | 10.43 | 0.1976 | 3.17 | 3.17 | 183.12 | 40.41 | -- | -- | -- | 61,135,500.00 | -- | 5.16 | -- | 11.56 | 6.85 | 10.01 | 1.73 | 2.05 | 1.19 | 2.00 | 0.3926 | -- | 32.11 | 25.76 | 17.75 | 45.07 | 157.98 | -- |
| Mono Pharmacare Ltd | 1.47bn | 8.18m | 191.70m | 115.00 | 23.56 | 0.614 | 19.86 | 0.13 | 0.4605 | 0.4605 | 77.21 | 17.67 | 1.35 | 2.71 | 2.76 | 12,823,770.00 | 0.7704 | -- | 1.53 | -- | 8.63 | -- | 0.5716 | -- | 1.08 | 1.12 | 0.6376 | -- | 37.60 | -- | 26.52 | -- | -- | -- |
